FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2052019 · Received April 12, 2011

Report

Report Number
2124215-2011-03992
Event Type
Injury
Date Received
April 12, 2011
Date of Event
February 22, 2011
Report Date
February 22, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
PMA / PMN Number
P910073
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

ALL AVAILABLE INFORMATION INDICATES THAT THIS PRODUCT REMAINS IN SERVICE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS TRANSVENOUS DEFIBRILLATION LEAD WAS HOSPITALIZED AFTER EXPERIENCING SYNCOPE. IT WAS NOTED THAT THIS PATIENT HAD A 12 SECOND PAUSE IN PACING. PATIENT ISOMETRICS AND MANIPULATIONS WERE PERFORMED, AND THE LOSS OF CAPTURE COULD NOT BE RECREATED. IT WAS FURTHER NOTED THAT WHEN THE LEFT VENTRICULAR (LV) LEAD WAS PROGRAMMED OFF, GOOD RV PACING AND CAPTURE WERE OBSERVED. THERE WAS ALSO A HISTORY OF NOISE ON THE SHOCK CHANNEL. ALL OTHER LEAD MEASUREMENTS WERE NOTED TO BE NORMAL. TECHNICAL SERVICES (TS) DISCUSSED THE POSSIBILITY OF THE TWO INSTANCES OF PREVIOUS NOISE COULD HAVE BEEN DUE TO THE MECHANICAL INTERACTION OF A TEMPORARY PACING WIRE WHILE THE PATIENT WAS HOSPITALIZED. TS ALSO DISCUSSED THAT IT WAS UNKNOWN AT THIS TIME WHAT CAUSED THE REPORTED ASYSTOLE. ADDITIONAL INFORMATION WAS PROVIDED THAT THE RIGHT VENTRICULAR (RV) SENSITIVITY WAS DECREASED TO LEAST TO AVOID OVERSENSING OF ATRIAL ACTIVITY. NO OTHER ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0148

Patients

Seq Age Sex Outcome Treatment
1 78 YR Life Threatening 1861| 4543| 4549| 0148| 4017| T127| H210